Fate Therapeutics Inc
About
Fate Therapeutics Inc (NASDAQ:FATE) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 16 2026
Fate Therapeutics Announces Data Presentation of FT839 Next-Generation Off-The-Shelf CAR T-Cell Product Candidate for the Broad Treatment of Hematological Malignancies and Autoimmune Diseases Without the Need for Conditioning Chemotherapy at the AACR Annual Meeting
Apr 16 2026
Fate Therapeutics Announces Data Presentation of FT839 Next-Generation Off-The-Shelf CAR T-Cell Product Candidate for the Broad Treatment of Hematological Malignancies and Autoimmune Diseases Without the Need for Conditioning Chemotherapy at the AACR ...
Apr 9 2026
Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences
Mar 3 2026
Fate Therapeutics to Participate in Leerink Partners 2026 Global Healthcare Conference
Feb 26 2026
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Financials
Revenue
$6.65 M
Market Cap
$141.84 M
EPS
-1.15